Walgreens Boots Alliance Inc (WBA) : Tiemann Investment Advisors reduced its stake in Walgreens Boots Alliance Inc by 1.49% during the most recent quarter end. The investment management company now holds a total of 24,765 shares of Walgreens Boots Alliance Inc which is valued at $1,967,084 after selling 374 shares in Walgreens Boots Alliance Inc , the firm said in a disclosure report filed with the SEC on May 2, 2016.Walgreens Boots Alliance Inc makes up approximately 1.96% of Tiemann Investment Advisors’s portfolio.
Walgreens Boots Alliance Inc closed down -2.03 points or -2.49% at $79.43 with 1,14,11,582 shares getting traded on Friday. Post opening the session at $79, the shares hit an intraday low of $78.24 and an intraday high of $79.5 and the price fluctuated in this range throughout the day.Shares ended Friday session in Red.
Other Hedge Funds, Including , Seven Bridges Advisors reduced its stake in WBA by selling 4,408 shares or 18.66% in the most recent quarter. The Hedge Fund company now holds 19,209 shares of WBA which is valued at $1,525,771. Walgreens Boots Alliance Inc makes up approx 1.22% of Seven Bridges Advisors’s portfolio.Huntington National Bank boosted its stake in WBA in the latest quarter, The investment management firm added 15,946 additional shares and now holds a total of 122,405 shares of Walgreens Boots Alliance Inc which is valued at $9,704,268. Walgreens Boots Alliance Inc makes up approx 0.25% of Huntington National Bank’s portfolio.Chemung Canal Trust Co reduced its stake in WBA by selling 385 shares or 2.76% in the most recent quarter. The Hedge Fund company now holds 13,573 shares of WBA which is valued at $1,087,740. Walgreens Boots Alliance Inc makes up approx 0.25% of Chemung Canal Trust Co’s portfolio.Sigma Planning Corp reduced its stake in WBA by selling 1,614 shares or 14.3% in the most recent quarter. The Hedge Fund company now holds 9,670 shares of WBA which is valued at $774,954. Walgreens Boots Alliance Inc makes up approx 0.10% of Sigma Planning Corp’s portfolio.
On the company’s financial health, Walgreens Boots Alliance Inc reported $1.31 EPS for the quarter, beating the analyst consensus estimate by $ 0.03 according to the earnings call on Apr 5, 2016. Analyst had a consensus of $1.28. The company had revenue of $30184.00 million for the quarter, compared to analysts expectations of $30666.29 million. The company’s revenue was up 13.6% compared to the same quarter last year. During the same quarter in the previous year, the company posted $1.18 EPS.
Many Wall Street Analysts have commented on Walgreens Boots Alliance Inc. Shares were Reiterated by Barclays on Mar 10, 2016 to “Equal Weight” and Lowered the Price Target to $ 76 from a previous price target of $81 .Mizuho Upgraded Walgreens Boots Alliance Inc on Mar 1, 2016 to ” Buy”, Price Target of the shares are set at $90.Walgreens Boots Alliance Inc was Initiated by Atlantic Equities to “Neutral” on Feb 3, 2016.
Walgreens Boots Alliance Inc. (Walgreens Boots Alliance) is a holding company. The Company is a global pharmacy-led health and wellbeing enterprise. It operates through three segments: Retail Pharmacy USA which consists of the Walgreens business including the operation of retail drugstores and convenient care clinics in addition to providing specialty pharmacy services; Retail Pharmacy International which consists of the Alliance Boots pharmacy-led health and beauty stores optical practices and related contract manufacturing operations and Pharmaceutical Wholesale which consists of the Alliance Boots pharmaceutical wholesaling and distribution businesses. Its portfolio of retail and business brands includes Walgreens Duane Reade Boots and Alliance Healthcare as well as global health and beauty product brands including No7 Botanics and Soap & Glory. Walgreens Boots Alliance through its subsidiary Liz Earle Beauty Co. Ltd offers the Liz Earle skincare brand.